Co-delivery of plantamajoside and sorafenib by a multi-functional nanoparticle to combat the drug resistance of hepatocellular carcinoma through reprograming the tumor hypoxic microenvironment-Reference-Cited by-同舟云学术

Co-delivery of plantamajoside and sorafenib by a multi-functional nanoparticle to combat the drug resistance of hepatocellular carcinoma through reprograming the tumor hypoxic microenvironment

Published:2019-01-01 Issue:1 Volume:26 Page:1080-1091
ISSN:1071-7544
Container-title:Drug Delivery
language:en
Short-container-title:Drug Delivery

Author:

Zan Ying¹,Dai Zhijun¹,Liang Liang¹,Deng Yujiao¹,Dong Lei¹

Affiliation:

1. Department of Digestive, The Second Hospital of Xi'an Jiaotong University, Xian, China

Publisher

Informa UK Limited

Subject

Pharmaceutical Science,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/10717544.2019.1654040

Reference36 articles.

1. Activation of STAT3/HIF-1α/Hes-1 axis promotes trastuzumab resistance in HER2-overexpressing breast cancer cells via down-regulation of PTEN

2. miR-338-3p inhibits epithelial-mesenchymal transition and metastasis in hepatocellular carcinoma cells

3. High Levels of TRIM14 Are Associated with Poor Prognosis in Hepatocellular Carcinoma

4. Fluconazole-loaded solid lipid nanoparticles topical gel for treatment of pityriasis versicolor: formulation and clinical study

5. Multi-targeting Peptide-Functionalized Nanoparticles Recognized Vasculogenic Mimicry, Tumor Neovasculature, and Glioma Cells for Enhanced Anti-glioma Therapy

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent Review on Biological Barriers and Host–Material Interfaces in Precision Drug Delivery: Advancement in Biomaterial Engineering for Better Treatment Therapies;Pharmaceutics;2024-08-16

2. Research progress of sorafenib drug delivery system in the treatment of hepatocellular carcinoma: An update;Biomedicine & Pharmacotherapy;2024-08

3. Advances in hepatocellular carcinoma drug resistance models;Frontiers in Medicine;2024-07-31

4. C-X-C motif chemokine receptor 4 inhibition promotes the effect of plantamajoside in hepatocellular carcinoma;Arab Journal of Gastroenterology;2024-02

5. Targeting metabolic reprogramming in hepatocellular carcinoma to overcome therapeutic resistance: A comprehensive review;Biomedicine & Pharmacotherapy;2024-01